{"id":"W4283516981","doi":"10.1016/j.msard.2022.103995","title":"Use of natalizumab in persons with multiple sclerosis: 2022 update","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Université de Sherbrooke; University of British Columbia; Memorial University of Newfoundland; Western University","funders":"","keywords":"Natalizumab; Medicine; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Dosing; Adverse effect; Intensive care medicine; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009182937,0.0008323614,0.001922305,0.002595874,0.0001635712,0.001075534,0.0009998584,0.00123645,0.00464461],"category_scores_gemma":[0.002219567,0.0003608617,0.001270432,0.00203458,0.0002788893,0.00108096,0.0005923322,0.001450937,0.001088499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006603024,"about_ca_system_score_gemma":0.001672469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002509018,"about_ca_topic_score_gemma":0.00753284,"domain_scores_codex":[0.9995759,0.00008965832,0.0001260287,0.00004923921,0.0001287972,0.00003034451],"domain_scores_gemma":[0.9988142,0.0005570366,0.0003445269,0.00001789477,0.000210142,0.00005610314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000375208,0.00006373498,0.0005154336,0.0491141,0.0007254547,0.0001914716,0.00004251362,0.0002330255,0.0007397122,0.0005538437,0.05044996,0.8969955],"study_design_scores_gemma":[0.0004774652,0.0003490413,0.004416127,0.03164653,0.004164116,0.002014986,0.00006492119,0.000220058,0.0003584883,0.0006195682,0.955614,0.00005463889],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000091957,0.9989402,0.00004809679,0.0002281171,0.0002117113,0.000004805683,0.00006138944,0.000006944731,0.0004068374],"genre_scores_gemma":[0.0006715555,0.998166,0.0001303122,0.0005239351,0.0002317777,0.000008212361,0.00007790652,0.000001820143,0.0001885778],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00464461,"threshold_uncertainty_score":0.01553774,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07109589134726166,"score_gpt":0.2656694784780308,"score_spread":0.1945735871307691,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}